#FT120 #Next40 | 🏆 Elles sont 120 pépites, elles sont les géants français de la #tech de demain. Bravo aux #startup sélectionnées pour intégrer le programme #FrenchTech Next 40/120, édition 2022 ! 👏

Thrilled to share we're named to the La French Tech #Next40, a #French gov-sponsored list showcasing the country’s most promising #startups! It's an honor to be among companies who are disrupting industries & driving innovation. More in TechCrunch: ow.ly/RPwE50HJLmP #synbio

We've been named to the Fast Company Most Innovative Companies 2022 list! Our #EDS technology & #SYNTAX System are accelerating workflow and democratizing access to #syntheticDNA. It's an honor to be included. ow.ly/l63450IcLJc #FCMostInnovative #enzymaticDNAsynthesis

The secret is out of the box @Mercerlab & Bas Edna are very excited about our new cutting edge equipment! DNA Script #SYNTAX has arrived AIBN Research AGRF ltd.. First install in the Southern Hemisphere! A new era in #synbio using #enzymaticsynthesis to produce #DNA #RNA #mRNA

Welcome #lifescience veteran Chris Barbazette as our new Chief Commercial Officer. He will play a pivotal role in driving our continued commercial growth. We're thrilled he has joined the team! More: ow.ly/PLV050J3RVw #biotech #leadership #enzymaticDNAsynthesis #DNAonDemand

Welcome to @DNAscript, Chris Barbazette! We’re thrilled to have you on board to help bring our disruptive #enzymaticDNAsynthesis technology to the world. #leadership #SYNTAX #DNAonDemand #biotech #EDS

As #AGBT22 closes, we're grateful to connect with other game-changing #biotech companies, friends & colleagues, and showcase the latest capabilities of #SYNTAX to accelerate #genomics workflows. Take a look back this year’s conference. Looking fwd to next year! AGBT Meeting

In our latest App Note we present the 1st report of viral smFISH in the gut of Drosophila melanogaster, performed with fluorophore-labeled DNA probes produced in-house on a benchtop #SYNTAX System as an alternative to immunofluorescence. More: ow.ly/9UJo50Jwivk #DNAonDemand

Un prototype tourne déjà dans les laboratoires de la Direction générale de l'armement, qui veut avoir accès aux nouveaux kits Syntax pour mieux détecter les menaces infectieuses à venir. trib.al/idDh3Ly

Happy to share: Direction générale de l'armement 🇫🇷 - Direction générale de l'armement has used the #SYNTAX System to successfully develop DNA primers and probes for #qPCR assays, working toward on-demand detection of biothreats. We’re thrilled to extend this collaboration! #DNAonDemand #EnzymaticDNASynthesis

Happy to share that our work with Harvard SEAS & Broad Institute in our IARPA program has just published in Science Advances! pH control on CMOS chip can lead to high-throughput #enzymaticDNA synthesis 🧬 Read more: ow.ly/hl7W50K5K2p

DNA Script colleague Sylvain Gariel and Antoine Papiernik of Sofinnova Partners authored a piece in Les Echos on the importance of investing in #healthcare structure and #vaccine production so France is prepared for the next global #pandemic. More: ow.ly/jkoY50KIlhF #innovation

Le Grand Prix des Trophées des Futures Licornes 2022 revient à DNA Script, déjà lauréate du prix Biotech, Medtech en 2021 ! Félicitations à Xavier Godron, Blanche Savary de Beauregard et Sophie Peresson, ainsi qu’à toutes leurs équipes ! #FuturesLicornes2022

Demand is growing for same-day #EnzymaticDNASynthesis, as we’ve expanded to the Middle East! We've partnered with leading distributors in the Gulf region & Israel, plus expanded our Asia Pacific coverage to Japan. Full press release: ow.ly/oF1O50L7Aeu

New research from the AIBN Research, published in Nature Communications, shows the value of using #EnzymaticDNAsynthesis to produce DNA #oligos in house to accelerate innovation. The research team manufactured CAPTORS (control library adaptors) using the benchtop #SYNTAX System printer.

Delighted to be acknowledged by La French Tech SF for the 3rd year, as 1 of 40 most successful start-ups spearheading the French economy. This year we were asked to commitment to climate leadership, parity in the workplace, and inclusion bit.ly/DNAScript40 #DNA #Genomics

Congratulations to our advanced research group on their recent publication accepted by Science Magazine about the benchtop enzymatic ink jet #DNA printer.bit.ly/DNAScript-inkj…

💡 Découvrez #Antibiogo ! 🔬 Cette application révolutionnaire a été mise au point par Fondation MSF avec Google.org pour lutter contre la résistance aux antibiotiques, 1ère cause de mortalité au monde d’ici 2050 d’après l’OMS. #IA #HealthTech #TechForGood

DNA writing technologies moving toward synthetic genomes nature.com/articles/s4158…

New results from a phase 1 clinical trial of the messenger RNA (#mRNA)-based therapeutic cancer vaccine autogene cevumeran are now published in the journal nature. The experimental approach to treating #pancreaticcancer continues to show potential to stimulate an immune